Xin Lang Cai Jing·2026-01-23 01:40Group 1 - The core viewpoint of the news is that BeiGene's stock performance and financing activities indicate a mixed sentiment among investors, with a notable increase in shareholder numbers and significant revenue growth reported [1][2]. Group 2 - On January 22, BeiGene's stock fell by 1.77%, with a trading volume of 583 million yuan. The financing buy-in amount was 51.87 million yuan, while the financing repayment was 43.98 million yuan, resulting in a net financing buy of 7.89 million yuan. The total financing and securities balance reached 871 million yuan [1]. - As of January 22, BeiGene's financing balance was 864 million yuan, accounting for 2.61% of its market capitalization, which is below the 40th percentile level over the past year, indicating a low financing level [1]. - On the same day, BeiGene's securities lending saw a repayment of 2,694 shares and a sale of 32 shares, with a selling amount of 9,193.60 yuan. The securities lending balance was 727.21 million yuan, exceeding the 50th percentile level over the past year, indicating a high level of securities lending [1]. - As of September 30, BeiGene had 36,200 shareholders, an increase of 55.33% from the previous period, while the average number of circulating shares per person decreased by 35.79% to 3,195 shares [2]. - For the period from January to September 2025, BeiGene reported a revenue of 27.595 billion yuan, representing a year-on-year growth of 44.21%, and a net profit attributable to shareholders of 1.139 billion yuan, reflecting a significant increase of 130.88% [2]. - Among the top ten circulating shareholders as of September 30, 2025, notable changes included a decrease in holdings by several funds, while new shareholders entered the list, indicating a shift in institutional interest [2].